Tag: Catalent partnership with Novo Holdings

news-21102024-151856

Catalent’s Deal with Novo Holdings: Customer Reassurance and Updates

Catalent, a major contract drug manufacturer, recently reassured its customers through an open letter that its proposed acquisition by Novo Nordisk’s parent company for $16.5 billion would not impact its ability to provide services...